+86-571-8627 3270
NINGBO TEAM PHARMACEUTICALS CO.,LTD
32 YRS
Zhejiang, China
CNY 415 Million
127872 m²
100-500 people
Main Products: Gemcitabine Hydrochloride / Ondansetron Hydrochloride / Granisetron Hydrochloride / Toremifene Citrate / Baclofen / Carvedilol / Doxofylline
Zhejiang, China
ABOUT US
Fuan Pharmaceutical Group Ningbo Tianfeng Pharmaceutical Co., Ltd., a subsidiary of Fuan Pharmaceutical (Group) Co., Ltd., formerly Ningbo Tianfeng Pharmaceutical Co., Ltd., and later acquired by Fuan Pharmaceutical Group, is the group's site of production of antineoplastic drug substances and formulations. Fu An Pharmaceutical Group Ningbo Tianfeng Pharmaceutical Co., Ltd., located in Zhenhai Zhuang Industrial Zone of Ningbo, China, is a new pharmaceutical enterprise mainly based on the development and production of high-tech chemicals, with the integration of science, industry and trade. Founded in August 1992, with over twenty vehicles in medicine, Tianfeng has fully passed national GMP certification. Enterprise has the first class of pharmaceutical science and technology strength and research center of medicine science and technology in China, first set a postdoctoral scientific research flow station in 2005, the postdoctoral workstation successfully developed numerous national class II and class IV new drugs that are at the leading edge of the country and have reached the advanced level of the world, which strongly fills the gap in the domestic pharmaceutical industry; Enterprise in Ningbo pharmaceutical industry enterprise, high scientific research technology, high-tech products, economic benefits and development speed are the top ranked, and has received more than 50 awards, at the same time, as the first national high technology enterprise, it was reexamined in 2014. The total plant area of the company is 128010 m2, including 61343 m2 in Zhuang, 24900 m2 in construction and 35679 m2 in greening; The new plant for pharmaceutical materials in Petrochemical Economic and Technological Development Zone covers 66667 M2 (100mu) with a building area of 41179 m2. The main products of the enterprises are "" Shudan "", "" Shuxing "", "" Shulida "" Et al., to date, many national class II and class IV new drugs have been developed and developed, now own 96 products of multiple dosage forms of crude drugs, injections, tablets, etc., more than 70 varieties, of which more than 20 varieties are rated as national key new products, listed in the national torch program, received the National Award for scientific and technological progress, Zhejiang Province Award for scientific and technological progress, and received the national small to medium innovation bonus for scientific and technological innovation; And has declared 2 well-known brands and 2 provincial famous trademarks. The marketing network is all over the country, the marketing team is growing, the products are best-selling domestic and sold far from the United States, Japan, India, etc., and is deeply welcomed by domestic and foreign customers.
Basic Information
Tax ID
91330211144072003N
Country/Region
Zhejiang, China
Year Established
1992
Registered Capital
CNY 415 Million
Business Type
CRO
Total Employees
100-500 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
Antineoplastic drug substance and formulation manufacturing sites.
PLANT LOCATION
COMPANY ALBUM
厂房大门
厂房大门
厂房大门
厂房大门
办公区域
公司参展
公司活动
其他图片
其他图片
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >